Trump’s COVID-19 diagnosis is a ‘cautionary tale for everyone,’ UNMC doctor says

Roughly 2,800 Nebraskans ages 65 to 74 have tested positive for COVID-19, state figures show. About 1,900 of them, almost 68%, have recovered, while 470 wound up in the hospital, and 102, or 3.6%, died.

On the plus side, the president, by virtue of his position, has access to world-class medical care.

While people who are hospitalized with more severe cases of COVID-19 may receive oxygen, convalescent plasma, the antiviral drug remdesivir or the steroid dexamethasone, among other treatments, there currently are no approved treatments for preventing a more serious course of the disease or hospitalization, Rupp said.

The Washington Post recently reported that several pharmaceutical companies are working to develop lab-made monoclonal antibodies in the hopes of preventing infection after someone has been exposed to the coronavirus, or keeping people from getting so sick that they end up in a hospital care or on a ventilator. But those antibody treatments are still in the clinical trial phase, Rupp said, and have not been approved by the Food and Drug Administration.

On Friday afternoon, Trump’s doctor said he had received a dose of Regeneron Pharmaceutical’s experimental antibody cocktail, plus vitamins and minerals.